These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2553996)

  • 1. Preliminary pharmacokinetics of 2',3'-dideoxycytidine in neonatal goats.
    Williams RJ; Knight AP; Smith JA; Boudinot FD; Demartini JC; Dahlberg JE
    J Vet Pharmacol Ther; 1989 Sep; 12(3):334-9. PubMed ID: 2553996
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of pregnancy, mode of administration and neonatal age on the pharmacokinetics of zalcitabine (2', 3'-dideoxycytidine) in the pigtailed macaque (Macaca nemestrina).
    Tuntland T; Nosbisch C; Unadkat JD
    J Antimicrob Chemother; 1997 Nov; 40(5):687-93. PubMed ID: 9421317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a pharmacokinetic interaction between foscarnet and zalcitabine during concomitant administration?
    Aweeka FT; Brody SR; Jacobson M; Botwin K; Martin-Munley S
    Clin Ther; 1998; 20(2):232-43. PubMed ID: 9589815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the antiviral agent beta-L-3'-fluoro-2',3'-didehydro-2',3'-dideoxycytidine in rhesus monkeys.
    Asif G; Hurwitz SJ; Gumina G; Chu CK; McClure HM; Schinazi RF
    Antimicrob Agents Chemother; 2005 Feb; 49(2):560-4. PubMed ID: 15673733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS and related disorders.
    Klecker RW; Collins JM; Yarchoan RC; Thomas R; McAtee N; Broder S; Myers CE
    J Clin Pharmacol; 1988 Sep; 28(9):837-42. PubMed ID: 2852679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of food on pharmacokinetics of zalcitabine in HIV-positive patients.
    Nazareno LA; Holazo AA; Limjuco R; Passe S; Twardy SK; Min B; Massarella JW
    Pharm Res; 1995 Oct; 12(10):1462-5. PubMed ID: 8584481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
    Sandberg JA; Binienda Z; Lipe G; Rose LM; Parker WB; Ali SF; Slikker W
    Drug Metab Dispos; 1995 Aug; 23(8):881-4. PubMed ID: 7493557
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic profile of cefotaxime in goats.
    Atef M; Ramadan A; Afifi NA; Youssef SA
    Res Vet Sci; 1990 Jul; 49(1):34-8. PubMed ID: 2382053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.
    Boudinot FD; Schinazi RF; Doshi KJ; McClure HM; Chu CK
    Drug Metab Dispos; 1993; 21(5):855-60. PubMed ID: 7902248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of phosphatidyl-dideoxycytidine in hepatitis B-infected cells and enhanced hepatic uptake in mice.
    Hostetler KY; Korba BE; Sridhar CN; Gardner MF
    Antiviral Res; 1994 May; 24(1):59-67. PubMed ID: 7944313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
    Kelley JA; Litterst CL; Roth JS; Vistica DT; Poplack DG; Cooney DA; Nadkarni M; Balis FM; Broder S; Johns DG
    Drug Metab Dispos; 1987; 15(5):595-601. PubMed ID: 2891473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability of levamisole in non lactating ewes and goats.
    Galtier P; Escoula L; Camguilhem R; Alvinerie M
    Ann Rech Vet; 1981; 12(2):109-15. PubMed ID: 7342829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of 2-fluorodideoxycytidine (2FddC) in patients infected with human immunodeficiency virus.
    Williams PE; Muirhead GJ; Sereni D; Rousseau FS; Edelman K; Hooker M
    Br J Clin Pharmacol; 1993 Mar; 35(3):255-60. PubMed ID: 8385974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism and rate of placental transfer of zalcitabine (2',3'-dideoxycytidine) in Macaca nemestrina.
    Tuntland T; Nosbisch C; Baughman WL; Massarella J; Unadkat JD
    Am J Obstet Gynecol; 1996 Mar; 174(3):856-63. PubMed ID: 8633656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profile of cefotaxime in goats.
    Atef M; Ramadan A; Afifi NA; Youssef SA
    Dtsch Tierarztl Wochenschr; 1990 Aug; 97(8):324-7. PubMed ID: 2209455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of gentamicin following single-dose parenteral administration to goats.
    Garg SK; Verma SP; Uppal RP
    Br Vet J; 1995; 151(4):453-8. PubMed ID: 7552201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interspecies scaling and pharmacokinetic parameters of 3TC in humans.
    Hussey EK; Donn KH; Daniel MJ; Hall ST; Harker AJ; Evans GL
    J Clin Pharmacol; 1994 Oct; 34(10):975-7. PubMed ID: 7530728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous bioavailability of levamisole in goats.
    Sahagún AM; García JJ; Sierra M; Fernández N; Diez MJ; Terán MT
    J Vet Pharmacol Ther; 2000 Jun; 23(3):189-92. PubMed ID: 11110108
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacokinetics and safety profile of oral ganciclovir combined with zalcitabine or stavudine in asymptomatic HIV- and CMV-seropositive patients.
    Jung D; AbdelHameed MH; Teitelbaum P; Dorr A; Griffy K
    J Clin Pharmacol; 1999 May; 39(5):505-12. PubMed ID: 10234599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioavailability of nimesulide in goats.
    Rao GS; Malik JK; Siddaraju VB; Shankaramurthy NC
    J Vet Pharmacol Ther; 2007 Apr; 30(2):157-62. PubMed ID: 17348902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.